The World Health Organization (WHO) has released a comprehensive new guideline on the use of non-sugar sweeteners (NSS), commonly known as artificial or low-calorie sweeteners, advising against their prolonged use for controlling body weight or reducing the risk of noncommunicable diseases. This significant recommendation stems from an extensive review of scientific evidence, which has ignited discussion among public health experts, researchers, and consumers regarding the long-term implications of these widely used sugar substitutes.
WHO’s Core Recommendation and the Evidence Base
At the heart of the WHO’s guidance is the conclusion that replacing sugar with NSS does not offer a sustained benefit for weight loss in either adults or children over the long term. This finding challenges a prevailing assumption that these sweeteners are a straightforward tool for calorie reduction and weight management. The review, which synthesized data from numerous studies, indicated that while some short-term clinical trials showed a reduction in calorie intake when NSS replaced sugar-sweetened foods and beverages, this effect did not translate into significant, lasting weight loss.
Furthermore, the WHO’s analysis found no consistent impact of NSS on hunger or satiety levels. While some trials reported reduced feelings of hunger among participants using NSS, others observed an increased appetite, particularly in individuals consuming higher quantities of NSS-containing beverages. This inconsistency in reported effects on appetite regulation adds another layer of complexity to understanding the role of NSS in dietary patterns.
Observational Data and Concerns for Chronic Disease
Beyond weight management, the WHO guideline also highlights concerns raised by observational cohort studies. These studies, which track large groups of people over extended periods, have linked the long-term consumption of NSS-containing beverages to an increased risk of cardiovascular disease and premature death in adults. Additionally, a higher intake of NSS, whether added to beverages or foods, was associated with an elevated risk of developing type 2 diabetes.
However, the WHO acknowledges a significant caveat in interpreting these observational findings: the potential for "reverse causation." This phenomenon suggests that individuals already at higher risk for chronic diseases, such as those with a higher body mass index (BMI), obesity, or pre-existing metabolic risk factors, might be more inclined to opt for NSS as a perceived healthier alternative. In such cases, the NSS use may be a consequence of, rather than a cause of, their predisposed health conditions. Despite this, the consistency of these associations warrants further investigation and careful consideration. The review found no significant association between NSS intake and the risk of cancer or cancer-related deaths.
The Role of Diet and Sweetness Perception
Based on the totality of the evidence reviewed, the WHO strongly advises individuals to reduce their overall intake of sweet tastes, beginning from an early age. The organization emphasizes that NSS, by their nature, provide no nutritional value and therefore do not contribute positively to a balanced diet. The guideline specifically names common NSS such as acesulfame K, aspartame, saccharin, sucralose, and stevia. It is important to note that the WHO’s analysis did not encompass sugar alcohols (polyols) like maltitol, xylitol, and sorbitol, which are frequently found in processed foods and beverages.
Expert Reactions and the Harvard Perspective
Experts at the Harvard T.H. Chan School of Public Health have largely concurred with the WHO’s recommendation to moderate overall sweetness in the diet. However, they have also raised specific criticisms regarding the methodology of the WHO’s meta-analysis, particularly the exclusion of certain large-scale cohort studies. These omitted studies, involving over 100,000 participants, had previously indicated that substituting sugar-sweetened beverages with artificially sweetened ones was associated with less weight gain over time. This finding aligned with results from smaller, short-term randomized controlled trials.
Statistical modeling based on these excluded studies suggested that replacing one serving of a sugar-sweetened beverage with an artificially sweetened alternative could be linked to a 4% lower risk of total mortality, a 5% lower risk of cardiovascular disease-related mortality, and a 4% lower risk of cancer-related mortality. This presents a contrasting perspective on the potential benefits of NSS, particularly for individuals accustomed to high sugar intake.
Frank Hu, Chair of the Department of Nutrition at the Harvard T.H. Chan School of Public Health, offered a nuanced view. He stated, "For habitual consumers of sugar-sweetened beverages, artificially sweetened beverages can be used as a temporary replacement, although the best choices would be water and unsweetened coffee or tea." This suggests that while NSS might serve as a transitional tool, they are not the ultimate ideal for long-term health.
Background: The Rise of Non-Sugar Sweeteners
The emergence and widespread adoption of NSS can be traced back to the mid-20th century, driven by a growing awareness of the health implications of excessive sugar consumption, including rising rates of obesity, type 2 diabetes, and dental caries. Initially, NSS were marketed as a healthier alternative for diabetics and a tool for weight reduction. Over the decades, their use expanded significantly, becoming ubiquitous in diet sodas, yogurts, chewing gum, baked goods, and a myriad of other processed food products.
The development and approval of different NSS have followed a scientific and regulatory pathway, with each sweetener undergoing rigorous testing for safety. However, the long-term effects of consistent, high-level consumption in complex dietary patterns have remained a subject of ongoing scientific inquiry and public debate. The WHO’s latest guideline represents a significant step in consolidating and interpreting this growing body of research.
Aspartame Under Scrutiny: A Separate but Related Concern
Adding another dimension to the discussion surrounding NSS, the International Agency for Research on Cancer (IARC), an arm of the WHO, and the Joint Expert Committee on Food Additives (JECFA) recently released a risk assessment on aspartame. The IARC classified aspartame as a Group 2B carcinogen, meaning it has "limited evidence" of carcinogenicity in humans, specifically in relation to liver cancer. This classification has understandably raised public concern.
However, it is crucial to contextualize this finding. The JECFA reaffirmed its previous recommendation for an acceptable daily intake (ADI) of aspartame at 40 mg per kilogram of body weight. The committee stated that its review did not uncover evidence to alter this guideline, affirming that consuming aspartame within this range is safe. For an average 150-pound (68 kg) woman, this translates to a daily limit of approximately 2,727 mg of aspartame, equivalent to about eleven 12-ounce cans of diet soda, each containing roughly 250 mg. The IARC and JECFA concluded that the evidence on cancer risk from both animal and human studies was not convincing, and stressed the need for more comprehensive, long-term research, including randomized controlled trials.
Broader Implications and Future Directions
The WHO’s new guideline on NSS has significant implications for public health policy, food labeling, and consumer choices. It challenges the prevailing narrative that NSS are a universally beneficial tool for health and weight management, urging a more cautious and nuanced approach.
The recommendation to reduce overall sweetness in the diet, starting early in life, aligns with broader public health goals of promoting healthier eating patterns and preventing chronic diseases. This shift in perspective may encourage a greater focus on whole, unprocessed foods and beverages like water, unsweetened coffee, and tea as the primary choices for hydration and dietary intake.
The debate surrounding the WHO’s guidance underscores the ongoing need for robust, long-term research into the complex interplay between NSS, diet, metabolism, and chronic disease development. Understanding potential long-term effects, independent of reverse causation, is critical for providing accurate and actionable health advice to the public. As the scientific understanding evolves, so too will the recommendations and strategies aimed at fostering healthier populations. The conversation is far from over, and continued dialogue between researchers, policymakers, and the public will be essential in navigating the evolving landscape of food science and public health.
